Dowden Nathan J

Dowden Nathan J is listed in filings as President & COO at Entrada Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 4, 2026, including sale activity. Recent filings connect the profile to Entrada Therapeutics, Inc. (TRDA). The current snapshot covers public activity from Aug 20, 2024 to May 4, 2026. Reported amounts are shown as $230.0K to $155.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.